483
Inga PharmaceuticalsInga Pharmaceuticals – FDA 483, Jun 12, 2017
Record Details
Inga Pharmaceutical, a manufacturer in Tambaram, Chennai, India, was cited for significant deficiencies during an FDA inspection. Observations included inadequate instrument calibration, lack of label control procedures, and widespread failures within the quality unit regarding procedure adherence, scientific justification, and instruction specificity. The firm also lacked a defined sanitization frequency and failed to validate an Excel worksheet used for critical calculations.
View Company Profile
ID · 8edaf72b-a2fb-4f60-b740-e8255572b063
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.